Flumadine Articles
Research points to new therapy for HCV
15 December 2008
UK's bird flu vacc stocks "should rise 600%"
19 February 2007
US FDA prohibits poultry antivirals
27 March 2006
Amantadine finds new role as Tamiflu adjunct
20 March 2006
Forest disappoints, despite 17% EPS hike
24 January 2005
US HHS Sec seeks to assure on flu vaccine
1 November 2004
First human efficacy data with J&J's oral neuraminidase candidate
20 September 2000
Influenza drugs battle for supremacy, new prophylaxis data
29 September 1999
New Drugs, Vaccine Shift Balance In War Against Flu
30 September 1998
Gilead's Oral Flu Drug Nears Trials
3 February 1997
Antivirals "Now 9% Of Anti-Infectives Market"
11 March 1996
1ST QUARTER RESULTS VARY FOR US FIRMS
23 May 1994
NEW YORK STOCK COMMENT
1 November 1993
FOREST'S FLUMADINE APPROVED FOR FLU
27 September 1993
FOREST LABS IN MERCK & CO DEAL
3 August 1992
Showing 1-18 of 18 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
